Correction: Tmprss2 Is Essential for Influenza H1N1 Virus Pathogenesis in Mice

Annual influenza epidemics and occasional pandemics pose a severe threat to human health. Host cell factors required for viral spread but not for cellular survival are attractive targets for novel approaches to antiviral intervention. The cleavage activation of the influenza virus hemagglutinin (HA) by host cell proteases is essential for viral infectivity. However, it is unknown which proteases activate influenza viruses in mammals. Several candidates have been identified in cell culture studies, leading to the concept that influenza viruses can employ multiple enzymes to ensure their cleavage activation in the host. Here, we show that deletion of a single HA-activating protease gene, Tmprss2, in mice inhibits spread of mono-basic H1N1 influenza viruses, including the pandemic 2009 swine influenza virus. Lung pathology was strongly reduced and mutant mice were protected from weight loss, death and impairment of lung function. Also, after infection with mono-basic H3N2 influenza A virus body weight loss and survival was less severe in Tmprss2 mutant compared to wild type mice. As expected, Tmprss2-deficient mice were not protected from viral spread and pathology after infection with multi-basic H7N7 influenza A virus. In conclusion, these results identify TMPRSS2 as a host cell factor essential for viral spread and pathogenesis of mono-basic H1N1 and H3N2 influenza A viruses. Copyright: ß 2013 Hateuser et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. " SP and KS also contributed equally to this work.

[1]  K. Shirato,et al.  Middle East Respiratory Syndrome Coronavirus Infection Mediated by the Transmembrane Serine Protease TMPRSS2 , 2013, Journal of Virology.

[2]  G. Whittaker,et al.  Cleavage Activation of Human-adapted Influenza Virus Subtypes by Kallikrein-related Peptidases 5 and 12* , 2013, The Journal of Biological Chemistry.

[3]  Christian Drosten,et al.  The Spike Protein of the Emerging Betacoronavirus EMC Uses a Novel Coronavirus Receptor for Entry, Can Be Activated by TMPRSS2, and Is Targeted by Neutralizing Antibodies , 2013, Journal of Virology.

[4]  D. Steinhauer,et al.  Influenza HA Subtypes Demonstrate Divergent Phenotypes for Cleavage Activation and pH of Fusion: Implications for Host Range and Adaptation , 2013, PLoS pathogens.

[5]  H. Klenk,et al.  Characterization of the neuraminidase of the H1N1/09 pandemic influenza virus. , 2012, Vaccine.

[6]  K. Schughart,et al.  The Mouse as Model System to Study Host‐Pathogen Interactions in Influenza A Infections , 2012, Current protocols in mouse biology.

[7]  P. Nelson,et al.  Influenza and SARS-Coronavirus Activating Proteases TMPRSS2 and HAT Are Expressed at Multiple Sites in Human Respiratory and Gastrointestinal Tracts , 2012, PloS one.

[8]  Maria Zambon,et al.  Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives. , 2012, The Lancet. Infectious diseases.

[9]  H. Klenk,et al.  Aprotinin and similar protease inhibitors as drugs against influenza. , 2011, Antiviral research.

[10]  K. Schughart,et al.  Pathogenicity of different PR8 influenza A virus variants in mice is determined by both viral and host factors. , 2011, Virology.

[11]  Christian Drosten,et al.  Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response , 2011, Journal of Virology.

[12]  K. Schughart,et al.  Inhibition of lung serine proteases in mice: a potentially new approach to control influenza infection , 2011, Virology Journal.

[13]  D. A. Stein,et al.  Inhibition of Influenza Virus Infection in Human Airway Cell Cultures by an Antisense Peptide-Conjugated Morpholino Oligomer Targeting the Hemagglutinin-Activating Protease TMPRSS2 , 2010, Journal of Virology.

[14]  Jincun Zhao,et al.  A Transmembrane Serine Protease Is Linked to the Severe Acute Respiratory Syndrome Coronavirus Receptor and Activates Virus Entry , 2010, Journal of Virology.

[15]  Makoto Takeda,et al.  Efficient Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by the Transmembrane Protease TMPRSS2 , 2010, Journal of Virology.

[16]  K. Schughart,et al.  TMPRSS2 and TMPRSS4 Facilitate Trypsin-Independent Spread of Influenza Virus in Caco-2 Cells , 2010, Journal of Virology.

[17]  S. Pöhlmann,et al.  Novel insights into proteolytic cleavage of influenza virus hemagglutinin , 2010, Reviews in medical virology.

[18]  Hang Xie,et al.  Characterization of lentiviral pseudotypes with influenza H5N1 hemagglutinin and their performance in neutralization assays. , 2010, Journal of virological methods.

[19]  Semi Kim,et al.  Proteolytic Activation of the 1918 Influenza Virus Hemagglutinin , 2009, Journal of Virology.

[20]  M. Takeda,et al.  Efficient Multiplication of Human Metapneumovirus in Vero Cells Expressing the Transmembrane Serine Protease TMPRSS2 , 2008, Journal of Virology.

[21]  G. Kochs,et al.  Replication fitness determines high virulence of influenza A virus in mice carrying functional Mx1 resistance gene , 2007, Proceedings of the National Academy of Sciences.

[22]  H. Yamada,et al.  Proteases essential for human influenza virus entry into cells and their inhibitors as potential therapeutic agents. , 2007, Current pharmaceutical design.

[23]  H. Klenk,et al.  Proteolytic Activation of Influenza Viruses by Serine Proteases TMPRSS2 and HAT from Human Airway Epithelium , 2006, Journal of Virology.

[24]  P. Nelson,et al.  Phenotypic Analysis of Mice Lacking the Tmprss2-Encoded Protease , 2006, Molecular and Cellular Biology.

[25]  H. Klenk,et al.  The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[26]  P. Wright,et al.  Cleavage of Influenza A Virus Hemagglutinin in Human Respiratory Epithelium Is Cell Associated and Sensitive to Exogenous Antiproteases , 2002, Journal of Virology.

[27]  R. Webster,et al.  Characterization of the Influenza A Virus Gene Pool in Avian Species in Southern China: Was H6N1 a Derivative or a Precursor of H5N1? , 2000, Journal of Virology.

[28]  O. Zhirnov,et al.  Aprotinin aerosol treatment of influenza and paramyxovirus bronchopneumonia of mice. , 1994, Antiviral research.

[29]  N. Katunuma,et al.  Isolation and characterization of a novel trypsin-like protease found in rat bronchiolar epithelial Clara cells. A possible activator of the viral fusion glycoprotein. , 1992, The Journal of biological chemistry.

[30]  M. Vey,et al.  Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin‐like endoprotease. , 1992, The EMBO journal.

[31]  B. Gotoh,et al.  Isolation of factor Xa from chick embryo as the amniotic endoprotease responsible for paramyxovirus activation , 1992, FEBS letters.

[32]  M. Hamaguchi,et al.  An endoprotease homologous to the blood clotting factor X as a determinant of viral tropism in chick embryo. , 1990, The EMBO journal.

[33]  O. Zhirnov,et al.  High protection of animals lethally infected with influenza virus by aprotinin‐rimantadine combination , 1987, Journal of medical virology.

[34]  O. Haller,et al.  Natural, genetically determined resistance toward influenza virus in hemopoietic mouse chimeras. Role of mononuclear phagocytes , 1979, The Journal of experimental medicine.

[35]  H. Klenk,et al.  Activation of influenza A viruses by trypsin treatment. , 1975, Virology.

[36]  P. Choppin,et al.  Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide. , 1975, Virology.

[37]  村上 明子 Mini-plasmin found in the epithelial cells of bronchioles triggers infection by broad-spectrum influenza A viruses and Sendai virus , 2003 .

[38]  O. Zhirnov,et al.  Suppression of influenza virus replication in infected mice by protease inhibitors. , 1984, The Journal of general virology.